← 返回列表 › SCI 期刊 › 医学 › Exp Ther Med

Experimental and Therapeutic Medicine

Exp Ther Med

Print ISSN 1792-0981 Online ISSN 1792-1015
SCIE Q3 新锐3区 传统4区 开放获取 医学
影响因子 2026
2.2
↓ 0.1
5年均分
2.6
5-Year IF
H 指数
33
H-Index
年发文量
192
Articles / Year
出刊频率
Continuously Published
Pub. Frequency
创刊年份
2010
Founded Year
出版商
Spandidos Publ Ltd
Publisher
出版国家
Greece
Country
投稿参考 & 用户评分
🏆 期刊声誉
★★★★★
暂无
综合口碑评分,点击星星参与
⚡ 审稿速度
★★★★★
暂无
暂无实测数据,欢迎分享经验
💰 版面费用
★★★★★
暂无
暂无APC数据,欢迎分享经验
中科院分区
2026新锐分区 新体系
大类3区
医学Medicine
小类3区
医学:研究与实验
中科院2025年分区 传统体系
大类4区
医学Medicine
小类4区
医学:研究与实验
WoS 期刊 JCR 分区 (2026 · JIF) 综合 SCIE Q3
学科 收录集 JIF 分区 JIF 排名 JIF 百分位
实验与研究医学 Medicine, Research & Experimental SCIE Q3 120/191
37.2%
按 JCI 指标学科分区
学科 收录集 JCI 分区 JCI 排名 JCI 百分位
实验与研究医学 Medicine, Research & Experimental SCIE Q3 92/161 JCI 0.56
43.5%
Scopus 指标
CiteScore
1.5
综合引用得分
SJR
—
SCImago Journal Rank
SNIP
1.500
Source Normalized Impact
JCI
0.56
Journal Citation Indicator
数据来源:Scopus (CiteScore · SJR · SNIP) · Clarivate (JCI)。指标年份:2026年6月最新版。
期刊简介

Experimental and Therapeutic Medicine (Exp Ther Med) is a peer-reviewed, open-access international journal dedicated to advancing knowledge in the fields of experimental medicine and clinical therapeutics. Published by Spandidos Publications, the journal serves as a platform for the dissemination of original research and review articles that explore the molecular mechanisms, pathogenesis, and therapeutic strategies for a wide range of human diseases. Its scope encompasses cellular and molecular biology, pharmacology, immunology, oncology, cardiovascular and neurological disorders, as well as infectious diseases and regenerative medicine. The journal welcomes full-length original research papers, comprehensive reviews, case reports, and brief communications that present novel findings or synthesize existing evidence to guide clinical practice and further experimental investigation. The target audience includes biomedical researchers, clinical scientists, pharmacologists, and healthcare professionals seeking insights into translational medicine and therapeutic innovations. A notable feature of Experimental and Therapeutic Medicine is its open-access model, ensuring that all published articles are freely accessible to the global scientific community, thereby promoting the rapid exchange of knowledge. With a 2026 Impact Factor of 2.2000, the journal holds a JCR Quartile ranking of Q3 in the subject area of Medicine (3区), positioning it as a solid, mid-tier outlet for clinically relevant experimental research. Its consistent indexing in major databases, including PubMed and Scopus, further underscores its utility as a reliable resource for emerging and established researchers aiming to contribute to the development of effective therapeutic approaches.

历年影响因子 & 年发文量

上述信息均来源于网络,以官方发布为准,仅供参考。如有建议,欢迎反馈

生物行 © 2002–2026  All Rights Reserved.